Rui Lin

Rui Lin

Director/Board Member at Fidelity Asia Ventures Ltd. (Shanghai)

53 year
Health Technology
Finance
Health Services

Profile

Rui Lin is currently the Vice Chairman at Changzhou Bioregen Biological Pharmaceuticals Co., Ltd., Director at Sipai (Beijing) Network Technology Co., Ltd., Director at Beijing Meizhong Airui Cancer Hospital Co., Ltd., and Partner at Eight Roads Capital Advisors (Hong Kong) Ltd.
She previously held the position of Vice President at Fidelity Asia Ventures Ltd.
(Shanghai).
Ms. Lin's former positions include Director at Zhejiang Boner Medical Investment Management Co., Ltd., Director at YS Biopharma Co. Ltd., and Member-Supervisory Board at Shanghai Hile Bio-Technology Co., Ltd.
Ms. Lin received an MBA from The Wharton School of the University of Pennsylvania in 2000.

Rui Lin active positions

CompaniesPositionStart
Director/Board Member 2006-12-31
Director/Board Member -
Private Equity Investor -
Director/Board Member -
Director/Board Member 2020-12-02
All active positions of Rui Lin

Former positions of Rui Lin

CompaniesPositionEnd
Director/Board Member -
YS BIOPHARMA CO., LTD. Director/Board Member -
SHANGHAI HILE BIO-TECHNOLOGY CO., LTD. Director/Board Member -
See the detail of Rui Lin's experience

Training of Rui Lin

The Wharton School of the University of Pennsylvania Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Rui Lin's experience

Connections

100 +

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
SHANGHAI HILE BIO-TECHNOLOGY CO., LTD.

Health Technology

YS BIOPHARMA CO., LTD.

Health Technology

Private companies6

Finance

Health Technology

Health Services

Finance

Technology Services

Health Services

See company connections